Anthea Lee
Analyst, Jefferies
Replay available
Tarsus Pharmaceuticals, Inc. (TARS) Q2 2026 Earnings Call
Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) Q2 2026 earnings conference call, held 2026-08-06. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Eddie Hickman
Analyst, Guggenheim Securities
Jason Gerberry
Analyst, Bank of America
Neera Klase
Interim Chief Commercial Officer
Sarah Knives
Investor Relations
Seshadri Neervannan
Chief Operating Officer
Bobak Azamian
Chief Executive Officer and Chairman
Lachlan Hanbury-Brown
Analyst, William Blair
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Tarsus Pharmaceuticals, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.051 -- 00:00:05.336 Hello and welcome to Tarsus Pharmaceuticals' second quarter 2026 financial 00:00:05.336 -- 00:00:10.720 results conference call and announcement to acquire Alkias Pharmaceuticals. 00:00:10.720 -- 00:00:16.465 As a reminder, this call is being recorded and all participants are in listen-only mode. 00:00:16.465 -- 00:00:20.508 After the speaker's presentation, there will be a question and answer session. 00:00:20.508 -- 00:00:24.732 At this time, I would like to turn the call over to Sarah Knives, Investor Relations, 00:00:24.732 -- 00:00:27.373 to lead off the call. 00:00:28.300 -- 00:00:32.841 Thank you. Before we begin, I encourage everyone to visit the Investors section of the 00:00:32.841 -- 00:00:37.682 TARCIS website to view the press releases issued today and related materials we will 00:00:37.682 -- 00:00:42.823 be discussing today. Joining me on the call are Bobak Azamian, 00:00:42.823 -- 00:00:47.823 our Chief Executive Officer and Chairman, Mira Clates, our Interim Chief 00:00:47.823 -- 00:00:53.364 Commercial Officer, Seshadri Neervannan, our Chief Operating Officer, 00:00:53.364 -- 00:00:58.109 and Jeff Farrow, our Chief Financial Officer and Chief Strategy Officer. 00:00:58.109 -- 00:01:04.411 and joining us for Q&A is Dr. Liz Yeu, our Chief Medical Officer. 00:01:04.411 -- 00:01:09.513 I'd like to draw your attention to slide three, which contains our forward-looking statements. 00:01:09.513 -- 00:01:13.734 During this call, we will be making forward-looking statements that are based on our 00:01:13.734 -- 00:01:19.096 current expectations and beliefs. These statements are subject to certain risks 00:01:19.096 -- 00:01:23.878 and uncertainties, and our actual results may differ materially. 00:01:23.878 -- 00:01:28.840...